News Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Delayed Bombay S.E. Other stock markets 05:32:38 2024-06-26 EDT			5-day change	1st Jan Change
1,379 ^INR	-1.67%		-1.45%	+1.79%

06-11	Caplin Point Laboratories Limited Appoints Thiagaraja Manikandan as Chief Transformation & Digital Officer	CI
05-24	Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Caplin Point Laboratories Limited Appoints Thiagaraja Manikandan as Chief Transformation & Digital Officer	06-11	CI
Ex-dividend day for interim dividend	05-30	FA
Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution	05-24	MT
Caplin Point Laboratories to Seek Acquisitions	05-16	CI
Transcript : Caplin Point Laboratories Limited, Q4 2024 Earnings Call, May 16, 2024	05-16
Caplin Point Laboratories Limited Declares an Interim Dividend for the Financial Year Ended March 31, 2024	05-16	CI
Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-16	CI
Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	05-06	MT
Caplin Point Laboratories Limited Receives Colombia's INVIMA Approval for Its Softgel Capsules Division At Puducherry	05-06	CI
Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	04-16	MT
Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication	03-28	MT
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	03-28	CI
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	03-27	MT
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	03-27	CI
Transcript : Caplin Point Laboratories Limited, Q3 2024 Earnings Call, Feb 09, 2024	02-09
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-09	CI
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	01-08	MT
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	01-08	MT
Caplin Point Laboratories Limited Announces Resignation of Hero Velladurai as President, R&D	12-14	CI
Transcript : Caplin Point Laboratories Limited, H1 2024 Earnings Call, Nov 09, 2023	11-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Summary

Filters